The Charing Cross Symposium (CX), established in 1978, has evolved into a leading global event in the vascular field. The 46th edition of CX, taking place at ExCeL London, continues to address vascular and endovascular controversies by engaging a global faculty in evidence-based discussions to achieve consensus on treatment approaches.
CX 2024 initiates a new three-year cycle focused on debating key controversies in the vascular and endovascular sectors. The aim is to scrutinise and challenge existing evidence, fostering a consensus through expert discussions.
Programme and Format
The symposium is structured to provide comprehensive coverage of vascular disease management, emphasising the importance of evidence in guiding treatment strategies. Sessions are characterised by short presentations and active audience participation, facilitated by chairs and moderators to ensure productive discussions.
CX 2024 is designed for a wide range of professionals in the vascular community, including:
- Vascular and Endovascular Surgeons
- Cardiovascular Specialists
- Interventional Radiologists
- Stroke Neurologists
- Imaging Specialists
- Vascular Nurses
- Trainee Physicians
CX 2024 offers an opportunity for over 4,000 participants to engage with the latest in vascular and endovascular care, through both in-person and online formats. The symposium encourages the sharing of knowledge, networking among professionals, and the discussion of innovative solutions in the management of vascular diseases.
